Avatrombopag (Doptelet®) – Immune thrombocytopenia (ITP)

1. Characteristics

Start date 01.04.2021
Resolution 16.09.2021
INN Avatrombopag
Brand name Doptelet®
Company Swedish Orphan Biovitrum GmbH
G-BA procedure ID 2021-04-01-D-649
ATC code B02BX08
ICD-10 codes D69.3Hemorrhagic (thrombocytopenic) purpura, D69.40, D69.41Evans syndrome
Therapeutic area Hematopoietic diseases
Reason for procedure New INN
Specialties Bundling

Indication (German)

Doptelet is used for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who do not respond to other therapies (e.g., corticosteroids, immunoglobulins).

Subgroup Indication Comparator
Erwachsene mit primärer chronischer Immunthrombozytopenie (ITP), die auf andere Therapien (z.B. Kortikosteroide, Immunglobuline) nicht ansprechen Eltrombopag oder Romiplostim

9. Associated procedures

Resolution INN Brand name Indication Additional benefit
Avatrombopag Doptelet® Immune thrombocytopenia (ITP)
Avatrombopag (2) Doptelet® Thrombocytopenia in chronic liver disease

<< List of all resolutions